p38α acts as a molecular switch to differentially regulate the Flt3 and CD115 pathways in dendritic cell development.

p38α is indispensable for plasmacytoid dendritic cell differentiation in a murine genetic model, and its loss triggers compensatory CD115 upregulation with functionally impaired DCs.

• Why it matters: DC development depends on balanced Flt3L and M-CSF signaling, but how these pathways are integrated to control lineage fate and downstream immune function is not fully understood.
• What they did: Using a murine genetic model, the study shows Flt3L→p38α sustains Nedd4 expression, which degrades CD115; p38α deletion downregulates Nedd4 and increases surface CD115 on hematopoietic progenitors.
• The result: Although p38α-deficient hematopoiesis numerically compensates pDCs and increases myeloid repopulation, the resulting DCs produce less type I/III interferons and IL-12, abrogating antitumor immunity and IFN-γ+ CD8+ T-cell responses, failing to control tumor growth.